SCHEMBL665266

SCHEMBL665266

COc1cc(O)c(C)c2c1CC(=O)C(c1ccccc1)O2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.51
ABCG2 Q9UNQ0 4/20 0.42
ABCB1 P08183 2/20 0.42
POLB P06746 2/20 0.41
MEN1 O00255 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
PABPC1 P11940 1/20 0.41
APEX1 P27695 1/20 0.41
RECQL P46063 1/20 0.41
KMT2A Q03164 1/20 0.41
EIF4H Q15056 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.38
SIRT1 Q96EB6 2/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28513252 0.88 CYP19A1 (0.46) CYP19A1ABCG2ABCB1POLBMEN1
SCHEMBL17907267 0.84 KMT2A (0.50) CYP19A1ABCG2ABCB1POLBMEN1
SCHEMBL28840935 0.83 CYP19A1 (0.46) CYP19A1ABCG2ABCB1POLBMEN1
SCHEMBL28879340 0.81 ABCG2 (0.42) CYP19A1ABCG2ABCB1POLBMEN1
SCHEMBL29085240 0.80 CYP19A1 (0.47) CYP19A1ABCG2ABCB1POLBMEN1
SCHEMBL664362 0.80 CYP19A1 (0.46) CYP19A1ABCG2ABCB1POLBMEN1
SCHEMBL15573731 0.79 ABCG2 (0.56) CYP19A1ABCG2ABCB1POLBMEN1
SCHEMBL17503283 0.78 NPC1 (0.45) CYP19A1ABCG2ABCB1POLBMEN1
SCHEMBL5084285 0.78 CYP19A1 (0.44) CYP19A1ABCG2ABCB1POLBMEN1
SCHEMBL6700109 0.78 CYP1A2 (0.38) CYP19A1ABCG2ABCB1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046353-A1 CLEISTOCALYX OPERCULATUS-DERIVED COMPOUNDS HAVING INHIBITORY ACTIVITIES AGAINST AVIAN AND SWINE INFLUENZA VIRUSES OR NOVEL INFLUENZA VIRUS CHOONG ANG VACCINE LAB. (KR) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046353-A1 CLEISTOCALYX OPERCULATUS-DERIVED COMPOUNDS HAVING INHIBITORY ACTIVITIES AGAINST AVIAN AND SWINE INFLUENZA VIRUSES OR NOVEL INFLUENZA VIRUS PIGS, CLEC4M, ENGASE CYP19A1 4094/4885ABCG2 1926/4885ABCB1 4746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.